These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12798671)

  • 41. Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model.
    Dudra-Jastrzebska M; Andres-Mach MM; Ratnaraj N; Patsalos PN; Czuczwar SJ; Luszczki JJ
    Seizure; 2009 Nov; 18(9):607-14. PubMed ID: 19628415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcranial photobiomodulation add-on therapy to valproic acid for pentylenetetrazole-induced seizures in peripubertal rats.
    Tsai CM; Chang SF; Chang H
    BMC Complement Med Ther; 2022 Mar; 22(1):81. PubMed ID: 35313886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Qualitative changes of anticonvulsant action of felbamate during development in rats.
    Haugvicová R; Kubová H; Mares P
    Brain Dev; 1998 Jun; 20(4):222-6. PubMed ID: 9661966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Aug; 45(8):895-907. PubMed ID: 15270754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A self-complementary, self-assembling microsphere system: application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate.
    Lian H; Steiner SS; Sofia RD; Woodhead JH; Wolf HH; White HS; Shen GS; Rhodes CA; McCabe RT
    J Pharm Sci; 2000 Jul; 89(7):867-75. PubMed ID: 10861587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-finding study with nicotine as a proconvulsant agent in PTZ-induced seizure model in mice.
    Sood N; Sahai AK; Medhi B; Chakrabarti A
    J Biomed Sci; 2008 Nov; 15(6):755-65. PubMed ID: 18668346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility.
    El-Mowafy AM; Abdel-Dayem MA; Abdel-Aziz A; El-Azab MF; Said SA
    Biochim Biophys Acta; 2011; 1811(7-8):460-7. PubMed ID: 21571092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of felbamate on muscarinic and metabotropic-glutamate agonist-mediated responses and magnesium-free or 4-aminopyridine-induced epileptiform activity in guinea pig olfactory cortex neurons in vitro.
    Libri V; Constanti A; Zibetti M; Nisticó S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1759-69. PubMed ID: 8667248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and pharmacodynamics of valproate analogues in rats. IV. Anticonvulsant action and neurotoxicity of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid.
    Liu MJ; Pollack GM
    Epilepsia; 1994; 35(1):234-43. PubMed ID: 8112253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood-brain barrier penetration of felbamate.
    Cornford EM; Young D; Paxton JW; Sofia RD
    Epilepsia; 1992; 33(5):944-54. PubMed ID: 1396440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models.
    Sills GJ; Butler E; Thompson GG; Brodie MJ
    Seizure; 2004 Jul; 13(5):287-95. PubMed ID: 15158698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Felbamate in the treatment of partial-onset seizures.
    Bourgeois BF
    Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Felbamate in experimental model of status epilepticus.
    Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
    Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
    Coffin V; Cohen-Williams M; Barnett A
    Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor.
    Kume A; Greenfield LJ; Macdonald RL; Albin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1784-92. PubMed ID: 8667250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticonvulsant profile of nimodipine and nitrendipine against pentylenetetrazole induced seizures in rats.
    Balakrishnan S; Bhargava VK; Pandhi P
    Indian J Exp Biol; 1999 Apr; 37(4):340-3. PubMed ID: 10641168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of felbamate on valproic acid disposition.
    Wagner ML; Graves NM; Leppik IE; Remmel RP; Shumaker RC; Ward DL; Perhach JL
    Clin Pharmacol Ther; 1994 Nov; 56(5):494-502. PubMed ID: 7955813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced seizures in mice.
    Joseph S; David J; Joseph T
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):383-8. PubMed ID: 9741653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M; Riva R; Albani F; Baruzzi AA
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.